control group:IA

2 trials

Sponsors

Shanxi Bethune Hospital of Shanxi Medical University, Department of Hematology, Jiangsu Province Hospital

Conditions

Acute Myeloid LeukemiaAcute myeloid leukemia

Phase 3

Decitabine/azacitidine in combinition with standard dose of IA regimen for newly diagnosed young patients with acute myeloid leukemia

Active, not recruitingChiCTR2000036086

Department of Hematology, Jiangsu Province HospitalAcute Myeloid Leukemia

Start: 2020-09-01Updated: 2020-09-07

Unknown Phase

A prospective, randomized, open, multicenter clinical study of dexithabine combined with IA and IA alone in primary acute myeloid leukemia

Active, not recruitingChiCTR2000034253

Shanxi Bethune Hospital of Shanxi Medical UniversityAcute myeloid leukemia

Start: 2020-07-23Updated: 2020-07-06